ICICI Lombard Q1 PAT falls 46% YoY to ₹403 Cr as claims spike, ₹165 Cr motor reserve bites
PAT -46% YoY · revenue +12% · margins compressing
₹6,807.91 Cr
+12% YoY
₹403.17 Cr
-46% YoY
5.92%
-6.4pp YoY
₹8.08
ICICI Lombard reported standalone Q1 FY27 (Jun-2026) PAT of ₹403.17 Cr, down 46.0% YoY from ₹747.08 Cr and 26.2% QoQ from ₹546.56 Cr, even as total income rose ~12% YoY to ₹6,813.71 Cr on net premium earned of ₹5,950 Cr (+15.8% YoY). Net margin compressed sharply to 5.9% from 12.3% a year ago. Basic EPS halved to ₹8.08 from ₹15.06. The print is weak on the bottom line despite healthy premium growth.
Q1 FY-2027 vs prior quarters
The profit fall is only partly a one-off. The company booked a prudent, conservative ₹165 Cr claim reserve on its Motor Third-Party book following the Supreme Court's June 11 2026 ruling recognising the economic value of homemakers' unpaid work for MV Act compensation; the GI Council has filed a review petition (Jul 10). Adjusting that back post-tax (~₹124 Cr) lifts PAT to ~₹527 Cr — still roughly 29% below the year-ago base, so the deterioration is structural, not cosmetic. The combined ratio worsened to 102.7% (vs 102.0% YoY, 101.2% QoQ) and the incurred-claims ratio rose to 76.4% from 73.0%, while operating investment income slipped 9% YoY to ₹857.9 Cr — the three drivers of the squeeze. Segmentally, Motor underwriting loss widened to ₹245.2 Cr (from ₹106 Cr YoY, where the TP reserve sits) and Health Group/Corporate stayed loss-making at ₹301.7 Cr.
The stock went into the print at ₹1,814.6, up 4.3% over the past month of trading.
For context: revenue is at a 5-quarter high.
Management anticipates the strong growth momentum from H2 FY26 to continue into early FY27, driven by Motor and exceptional growth in Retail Health. However, they explicitly warn of persistent and elevated pricing pressure in the Commercial lines segment, which is expected to continue in Q1 FY27 and could mute overall
— This quarter: missed
Against management's own Q4-FY26 concall guidance — strong growth into early FY27 led by Motor and Retail Health, disciplined Motor loss ratio of 65-67% and Retail Health 65-70% — the topline held (premiums grew double-digit and Retail Health net premium earned jumped ~50% YoY to ₹677 Cr) but the profitability targets were missed, with the combined ratio above breakeven and Motor loss ratios stretched by the reserve. The prior-call warning on Commercial-lines pricing pressure appears borne out in the weaker underwriting result. No published Street PAT consensus for the quarter was found (results released today); analyst 12-month targets cluster near ₹2,200. Alongside results, the board extended CIO Vinod Mahajan's tenure to Apr-2029 and confirmed the ₹7/share FY26 final dividend (approved at the Jun-19 AGM).
What to watch
W1
Combined ratio path: 102.7% in Q1 must fall toward <100% for underwriting to turn; guidance implied Motor loss ratio 65-67%
W2
Motor-TP reserve outcome: GI Council review petition (filed Jul 10 2026) on the SC ruling — could reverse or require further ₹165 Cr-type reserving
W3
Retail Health momentum (+~50% YoY net premium earned) vs its 65-70% loss-ratio target — key swing factor for FY27 profitability
Insurance two-account format (in Lakhs). revenueFromOps = net premium earned ₹5,950.04 Cr + operating investment income ₹857.87 Cr; +otherIncome ₹5.80 Cr = totalIncome ₹6,813.71 Cr (line 6). totalExpenses ₹6,579.92 Cr (line 12) yields operating profit ₹233.79 Cr; PBT ₹535.70 Cr is higher as it adds shareholders'-account investment income (~₹302 Cr), so totalIncome−totalExpenses≠PBT by design. PAT=PBT−tax checks. One-off: ₹165 Cr prudent Motor-TP claim reserve booked this quarter (SC homemakers-compensation ruling, Jun 11 2026); GI Council filed review petition Jul 10. No consolidated statement (standalone insurer).
Informational and educational content only. Not investment advice.